This year marks a significant milestone in cancer treatment as a revolutionary drug, first approved 25 years ago, continues to change the lives of patients with chronic myeloid leukemia (CML). Developed in Oregon, this groundbreaking therapy has saved countless lives and transformed cancer care. The Max Foundation is holding a webinar featuring experts like Pat Garcia-Gonzalez and Mei Ching Ong to reflect on the impact of this targeted therapy. The celebration highlights not only the scientific advancements achieved over the years but also the ongoing commitment to improving outcomes for leukemia patients globally.